3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Arthritis, Rheumatoid
5
Lymphoma, Large B-Cell, Diffuse
3
Lymphoma, B-Cell
3
Leukemia, Myeloid, Acute
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Lymphoma, Non-Hodgkin
2
Leukemia
2
Breast Neoplasms
2
Uveal Melanoma
1
Urinary Bladder Neoplasms
1
Unresectable Pancreatic Carcinoma
1
Solid Tumors
1
Small Cell Lung Carcinoma
1
Sarcoma, Kaposi
1
Pancreatic Adenocarcinoma
1
Ovarian Neoplasms
1
Myeloproliferative Disorders
1
Myelodysplastic-Myeloproliferative Diseases
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Multi-centric Castleman's Disease
1
Melanoma
1
Lymphoma
1
Lymphohistiocytosis, Hemophagocytic
1
Hodgkin Disease
1
Hematologic Neoplasms
1
Colitis
1
Castleman Disease
1
Carcinoma, Transitional Cell
1
Carcinoma, Neuroendocrine
1
Interventions
Nutrition Assessment
2
Collagenases
2
upadacitinib
1
tocilizumab
1
Vaccines
1
Transcutaneous Electric Nerve Stimulation
1
Saline Solution
1
Resistance Training
1
Omeprazole
1
Naproxen
1
Melphalan
1
Lysine Acetyltransferase 5
1
Injections, Intra-Articular
1
Immune Checkpoint Inhibitors
1
Herpes Zoster Vaccine
1
Febuxostat
1
Exercise Therapy
1
Colchicine
1
Cari-D-Tect
1
Arthroplasty, Replacement, Shoulder
1
Arthroplasty, Replacement, Elbow
1
Allopurinol
1
Adalimumab
1
Abatacept
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Arthritis
×
tocilizumab
×
Clear all
NCT03601611
2020-04-21
COLAR
Herlev Hospital
Phase NA
Completed
20 enrolled